< Back

December, 2016

The Impact of Recent Market Events on Cardiovascular Agents

BRAND ACCESS AND DISTRIBUTION INSIGHTS | RELEASED ON: 11/18/2016

FDA approvals and payer actions drive broader access barriers for brands. Plans increasingly demand convincing real-world data, particularly clinical advantages over generics, to assign improved access to current brands.

Recent FDA Approvals and Payer Actions Drive Broader Access Barriers for Brands

These and other findings can be found in Health Strategies Group’s recently released research Managed Care Complete: Cardiovascular Agents.

Key Questions Answered

  • How do commercial, Medicare, and managed Medicaid plans manage access to drugs in the category?
  • How do key market events and payer trends affect access for brands in the category?
  • How will payer management of the category evolve in the next few years?

Download Research Agenda

 

Pharmaceutical and biotech professionals with responsibility for brand-level payer strategies use Managed Care Complete to:

  • Evaluate current and future payer dynamics that directly impact the market and brand
  • Predict payer management of upcoming market events (e.g., new drug approvals, generic entrants)
  • Identify a comprehensive brand-level managed care strategy based on pipeline analysis
  • Tailor brand messaging and account management outreach by customers and plan types
  • Train field personnel on competitive dynamics and health plan needs to optimize access decisions
  • Forecast and incorporate payer insights in commercial and clinical development planning

 

Visit our Managed Care Complete webpage to learn more about this research.

 

Need another pharma fact?

How do commercial, Medicare, and managed Medicaid plans manage access to drugs in the hepatitis C category?

What stakeholders most expect to financially benefit from the availability of office-administered biosimilars?

How will payer management of the multiple sclerosis category evolve in the next few years?

How will payer management of the hypoglycemics category evolve in the next few years?

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.